The Compound on $ALAB (Nov 17, 2026)
ALAB's forward P/E has fallen to 46 times from 110 in June, de-rating the stock. It benefits when the data-center market is messier as the neutral connectivity supplier; selling the non-incumbent accelerator version gives it more business if data centers use a multitude of chips, and it rose until the last two days. Its EPS revisions are second strongest among peers, analysts agree, Q3 revenue was 585 million, up 154% year over year, with Q4 guidance of 730 to 750 million. The main constraint is that 70% of revenue comes from one customer, explaining why it is not more popular.
Playing via YouTube may share device and playback data and use cookies. Privacy Notice · Google Privacy Policy
Jump to any passage
I want to talk about Astera Labs. Forward PE is down to 46 times from 110 in June. Um, so this stock has deweeded. Astera does well when the data center market is messier because they are the Switzerland of connectivity.
Astera is selling the non-invidia version. And so if we're going to see a multitude of chips from Tranium to TPUs to AMD in these data centers, it's more business for Astera Labs.
And you're seeing um I think you've seen that in the stock up until the last two days. It's the second it's the second biggest EP uh EPS revision uh behind AMD. So the analysts agree with you.
Q3 revenue growth was 585 million which is a 154% year-over-year number and the Q4 guidance was 730 to 750 million. Now the reason why this is not a more popular stock is 70% of its revenue is one customer.